(Q61966035)
Statements
A Multi-Center, Open-Label, Dose Escalation, Phase 1 Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma (English)
0 references
25 April 2012
0 references
2 December 2014
0 references
79
0 references
18 year
0 references